Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 20, 2024

Total Value: $1.855B (100.0% shares, 0.0% debt)

Holdings (38)

VTI VANGUARD INDEX FDS 15.0%
Value $278M Shares 1,038,550 Share Price $267.51 Est. Cost/Share $267.51 Unrealized @ Report Date —
BN BROOKFIELD CORP 8.7%
Value $161M Shares 3,880,230 Share Price $41.54 * Est. Cost/Share $22.16 Unrealized @ Report Date +24.4%
TEM TEMPUS AI INC 7.7%
Value $143M Shares 4,074,419 Share Price $35.00 * Est. Cost/Share $30.66 Unrealized @ Report Date 0.0%
ASML ASML HOLDING N V 7.4%
Value $136M Shares 133,336 Share Price $1022.73 Est. Cost/Share $654.82 Unrealized @ Report Date —
CRM SALESFORCE INC 6.7%
Value $123M Shares 480,160 Share Price $257.10 * Est. Cost/Share $193.03 Unrealized @ Report Date +37.1%
EWTX EDGEWISE THERAPEUTICS INC 6.2%
Value $114M Shares 6,344,430 Share Price $18.01 * Est. Cost/Share $17.44 Unrealized @ Report Date 0.0%
CORT CORCEPT THERAPEUTICS INC 4.2%
Value $78.35M Shares 2,411,362 Share Price $32.49 * Est. Cost/Share $23.02 Unrealized @ Report Date +19.0%
PCVX VAXCYTE INC 3.9%
Value $71.73M Shares 950,000 Share Price $75.51 * Est. Cost/Share $31.07 Unrealized @ Report Date +119.1%
INSM INSMED INC 2.9%
Value $53.6M Shares 800,000 Share Price $67.00 * Est. Cost/Share $23.10 Unrealized @ Report Date +67.9%
MIRM MIRUM PHARMACEUTICALS INC 2.8%
Value $51.28M Shares 1,500,000 Share Price $34.19 * Est. Cost/Share $12.27 Unrealized @ Report Date +113.7%
CRNX CRINETICS PHARMACEUTICALS IN 2.4%
Value $44.79M Shares 1,000,000 Share Price $44.79 * Est. Cost/Share $19.36 Unrealized @ Report Date +138.5%
CABO CABLE ONE INC 2.3%
Value $41.91M Shares 118,403 Share Price $354.00 * Est. Cost/Share $987.67 Unrealized @ Report Date -62.4%
BMRN BIOMARIN PHARMACEUTICAL INC 2.2%
Value $40.34M Shares 490,000 Share Price $82.33 Est. Cost/Share $84.22 Unrealized @ Report Date -1.2%
— MERUS N V 2.2%
Value $39.94M Shares 675,000 Share Price $59.17 Est. Cost/Share $59.17 Unrealized @ Report Date —
AAPL APPLE INC 2.1%
Value $38.54M Shares 182,960 Share Price $210.62 * Est. Cost/Share $90.57 Unrealized @ Report Date +104.4%
BABA ALIBABA GROUP HLDG LTD 1.9%
Value $36.06M Shares 500,827 Share Price $72.00 Est. Cost/Share $165.09 Unrealized @ Report Date —
PHVS PHARVARIS N V 1.7%
Value $32.43M Shares 1,725,000 Share Price $18.80 * Est. Cost/Share $15.26 Unrealized @ Report Date +33.3%
CLDX CELLDEX THERAPEUTICS INC NEW 1.7%
Value $31.46M Shares 850,000 Share Price $37.01 Est. Cost/Share $37.73 Unrealized @ Report Date 0.0%
FDMT 4D MOLECULAR THERAPEUTICS IN 1.6%
Value $29.39M Shares 1,400,000 Share Price $20.99 * Est. Cost/Share $17.62 Unrealized @ Report Date +42.4%
— LANZATECH GLOBAL INC 1.6%
Value $29.26M Shares 15,814,845 Share Price $1.85 Est. Cost/Share $3.88 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 1.6%
Value $28.77M Shares 118,383 Share Price $243.00 * Est. Cost/Share $160.04 Unrealized @ Report Date -1.4%
AVBP ARRIVENT BIOPHARMA INC 1.5%
Value $27.82M Shares 1,500,000 Share Price $18.55 * Est. Cost/Share $19.51 Unrealized @ Report Date -8.6%
VRDN VIRIDIAN THERAPEUTICS INC 1.4%
Value $26.02M Shares 2,000,000 Share Price $13.01 * Est. Cost/Share $16.89 Unrealized @ Report Date -18.0%
— CARGO THERAPEUTICS INC 1.4%
Value $25.35M Shares 1,544,000 Share Price $16.42 Est. Cost/Share $21.87 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 1.3%
Value $24.8M Shares 2,500,000 Share Price $9.92 * Est. Cost/Share $12.83 Unrealized @ Report Date -20.0%
BAM BROOKFIELD ASSET MANAGMT LTD 1.3%
Value $23.87M Shares 627,207 Share Price $38.05 * Est. Cost/Share $31.11 Unrealized @ Report Date +19.7%
RCKT ROCKET PHARMACEUTICALS INC 1.3%
Value $23.68M Shares 1,100,000 Share Price $21.53 * Est. Cost/Share $28.09 Unrealized @ Report Date -18.2%
LXEO LEXEO THERAPEUTICS INC 1.3%
Value $23.27M Shares 1,450,500 Share Price $16.04 * Est. Cost/Share $13.07 Unrealized @ Report Date +11.1%
— BLUEPRINT MEDICINES CORP 1.0%
Value $18.86M Shares 175,000 Share Price $107.78 Est. Cost/Share $59.75 Unrealized @ Report Date —
KYTX KYVERNA THERAPEUTICS INC 0.7%
Value $13.13M Shares 1,750,000 Share Price $7.50 * Est. Cost/Share $20.30 Unrealized @ Report Date -24.7%
— MORPHIC HLDG INC 0.7%
Value $12.78M Shares 375,000 Share Price $34.07 Est. Cost/Share $34.07 Unrealized @ Report Date —
— VERVE THERAPEUTICS INC 0.6%
Value $11.71M Shares 2,400,000 Share Price $4.88 Est. Cost/Share $12.43 Unrealized @ Report Date —
MGX METAGENOMI INC 0.4%
Value $7.344M Shares 1,800,000 Share Price $4.08 * Est. Cost/Share $11.34 Unrealized @ Report Date -39.4%
IOBT IO BIOTECH INC 0.3%
Value $5.182M Shares 4,429,449 Share Price $1.17 * Est. Cost/Share $6.26 Unrealized @ Report Date -77.7%
ABCL ABCELLERA BIOLOGICS INC 0.2%
Value $3.336M Shares 1,126,915 Share Price $2.96 * Est. Cost/Share $8.47 Unrealized @ Report Date -55.3%
MQ MARQETA INC 0.1%
Value $2.42M Shares 441,558 Share Price $5.48 Est. Cost/Share $22.37 Unrealized @ Report Date -75.4%
— GALECTO INC 0.1%
Value $1.184M Shares 2,497,791 Share Price $0.47 Est. Cost/Share $12.51 Unrealized @ Report Date —
SPRO SPERO THERAPEUTICS INC 0.0%
Value $610K Shares 468,902 Share Price $1.30 * Est. Cost/Share $11.41 Unrealized @ Report Date -86.8%